Andris A. Zoltners is Director at Adaptive Biotechnologies Corp (ADPT). They have made 1 open-market trade across 1 company since 2020, most recently 2020-01-28.
CIK 0001780665
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADPT | 3,966,016 | $95.3M |
Shares reported on the most recent Form 4, priced at the 2020-01-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADPT | SELL | 2020-01-28 | 2020-01-29 | $26.50 | $9.1M | +2.8% | -7.8% | +4.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.